Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Specipig operates as a leading preclinical CRO specializing in the development, breeding, and commercialization of genetically defined miniature pigs ("Specipig®") as advanced large-animal models. Their animals are used by pharmaceutical, biotech, medical device companies, academic institutions, and other CROs to support translational research across multiple therapeutic areas. The company emphasizes high health status animals through rigorous biosafety protocols. They do not conduct clinical trials or have drug candidates themselves.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Specipig.